Study: Esophageal cancer survival rates tied to race, income
February 4, 2016 -- Esophageal cancer patients who are black and in lower socioeconomic groups have higher mortality rates than white patients with higher incomes, according to a new study presented at the recent meeting of the Society of Thoracic Surgeons.
Athenex gets FDA OK for clinical trials of oral form of cancer drug
February 3, 2016 -- Athenex has received U.S. Food and Drug Administration (FDA) allowance to proceed with clinical trials in patients of its oral form of the docetaxel anticancer drug, Oradoxel.
NYU, UCLA get $2.4M grant to study cannabinoids for cancer pain
January 29, 2016 -- The New York University (NYU) Bluestone Center for Clinical Research and the University of California, Los Angeles (UCLA) have received a five-year, $2.4 million grant from the National Cancer Institute to study the use of nonpsychotropic cannabinoids to suppress chronic cancer pain.
NCI cancer centers call for more HPV vaccinations
January 27, 2016 -- All 69 of the National Cancer Institute (NCI)-designated cancer centers issued a statement calling for an increase in the number of HPV vaccinations. announces the 2015 Dental Excellence Award winners
January 26, 2016 -- is pleased to announce the winners of the 2015 Dental Excellence Awards. Awards will be handed out at the Chicago Dental Society Midwinter Meeting in February.
Global Oral Cancer forum to take place in March
January 25, 2016 -- The inaugural Global Oral Cancer Forum will be held on March 4 and 5 at New York University in New York City.
U-M study finds natural dairy preservative kills cancer cells
January 22, 2016 -- University of Michigan (U-M) researchers have found that nisin, a naturally occurring preservative that grows on dairy products, killed between 70% and 80% of head and neck cancer tumor cells in rodents after nine weeks and extended survival in a new study, according to a university release.
Study: Data suggest novel approach to treat early-stage oral cancer
January 20, 2016 -- Of the many ongoing issues around oral cancer treatment is a lack of "significant improvement" in disease prognosis over the last several decades. Now a study in JAMA Otolaryngology -- Head and Neck Surgery presents, for the first time, outcome data for almost 250 patients using a novel optical approach at the point of care to treat early-stage oral cancer.
FDA fast-tracks Galera's oral mucositis therapy
January 12, 2016 -- The U.S. Food and Drug Administration (FDA) has granted fast-track status to Galera Therapeutics for a drug that may reduce the severity and incidence of radiation- and chemotherapy-induced oral mucositis.
Study: PET/CT aids radiation treatment in HNC patients
December 29, 2015 -- The use of PET/CT can improve radiation treatment planning for patients with head and neck cancers (HNCs), according to a review of studies that was recently published in the World Journal of Radiology.
Featured Free CE
Oral Cancer Awareness
For Oral Cancer Awareness DrBicuspid is providing the following two courses for Free to our Members. Oral Cancer: The Role of the Dental Professional Part 1 and Part 2
Special Feature
Aspirin can help battle head/neck cancer
Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer. Read more.
Dentifrices and Consumer Products
Dry Mouth Products
Tools and Instruments
Oral Cancer Detection